The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine

Research output: Contribution to journalArticle (Academic Journal)

54 Downloads (Pure)

Fingerprint Dive into the research topics of 'The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine'. Together they form a unique fingerprint.

Medicine & Life Sciences